ES450520A1 - Procedimiento para la obtencion de soluciones solubilizablesy estabilizadas de 2-cloro-11-(4-metil-i-piperazinil)-dibenz(b,f) (1,4) oxazepina. - Google Patents
Procedimiento para la obtencion de soluciones solubilizablesy estabilizadas de 2-cloro-11-(4-metil-i-piperazinil)-dibenz(b,f) (1,4) oxazepina.Info
- Publication number
- ES450520A1 ES450520A1 ES450520A ES450520A ES450520A1 ES 450520 A1 ES450520 A1 ES 450520A1 ES 450520 A ES450520 A ES 450520A ES 450520 A ES450520 A ES 450520A ES 450520 A1 ES450520 A1 ES 450520A1
- Authority
- ES
- Spain
- Prior art keywords
- solution
- oxazepine
- hydrochloric acid
- administratio
- parental
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- SFJGCXYXEFWEBK-UHFFFAOYSA-N oxazepine Chemical compound O1C=CC=CC=N1 SFJGCXYXEFWEBK-UHFFFAOYSA-N 0.000 title abstract 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- WXLCDTBTIVJDCE-UHFFFAOYSA-N 1,4-oxazepine Chemical compound O1C=CC=NC=C1 WXLCDTBTIVJDCE-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000012528 membrane Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60233175A | 1975-08-06 | 1975-08-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES450520A1 true ES450520A1 (es) | 1978-05-01 |
Family
ID=24410918
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES450520A Expired ES450520A1 (es) | 1975-08-06 | 1976-08-06 | Procedimiento para la obtencion de soluciones solubilizablesy estabilizadas de 2-cloro-11-(4-metil-i-piperazinil)-dibenz(b,f) (1,4) oxazepina. |
Country Status (19)
| Country | Link |
|---|---|
| JP (1) | JPS5221313A (en:Method) |
| AR (1) | AR210501A1 (en:Method) |
| AT (1) | AT345464B (en:Method) |
| AU (1) | AU500641B2 (en:Method) |
| BE (1) | BE844903A (en:Method) |
| CA (1) | CA1069823A (en:Method) |
| DE (1) | DE2633943A1 (en:Method) |
| DK (1) | DK147727C (en:Method) |
| EG (1) | EG12425A (en:Method) |
| ES (1) | ES450520A1 (en:Method) |
| FI (1) | FI762171A7 (en:Method) |
| FR (1) | FR2320102A1 (en:Method) |
| GB (1) | GB1546933A (en:Method) |
| IL (1) | IL49996A (en:Method) |
| NL (1) | NL7608575A (en:Method) |
| NO (1) | NO146457C (en:Method) |
| PT (1) | PT65400B (en:Method) |
| SE (1) | SE431716B (en:Method) |
| ZA (1) | ZA764052B (en:Method) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2739254B1 (fr) * | 1995-09-29 | 1997-12-19 | Rhone Merieux | Composition antiparasitaire pour le traitement et la protection des animaux de compagnie |
| FR2739255B1 (fr) * | 1995-09-29 | 1998-09-04 | Rhone Merieux | Composition antiparasitaire pour le traitement et la protection des animaux de compagnie |
| IE80657B1 (en) * | 1996-03-29 | 1998-11-04 | Merial Sas | Insecticidal combination to control mammal fleas in particular fleas on cats and dogs |
| WO2010106325A2 (en) | 2009-03-18 | 2010-09-23 | Omnipharm Limited | Parasiticidal formulation |
-
1976
- 1976-07-02 CA CA256,154A patent/CA1069823A/en not_active Expired
- 1976-07-07 ZA ZA764052A patent/ZA764052B/xx unknown
- 1976-07-08 IL IL49996A patent/IL49996A/xx unknown
- 1976-07-09 GB GB28752/76A patent/GB1546933A/en not_active Expired
- 1976-07-09 AU AU15775/76A patent/AU500641B2/en not_active Expired
- 1976-07-13 AR AR263933A patent/AR210501A1/es active
- 1976-07-22 PT PT65400A patent/PT65400B/pt unknown
- 1976-07-28 DE DE19762633943 patent/DE2633943A1/de not_active Withdrawn
- 1976-07-29 FI FI762171A patent/FI762171A7/fi not_active Application Discontinuation
- 1976-08-02 NL NL7608575A patent/NL7608575A/xx not_active Application Discontinuation
- 1976-08-04 EG EG475/76A patent/EG12425A/xx active
- 1976-08-05 SE SE7608810A patent/SE431716B/xx unknown
- 1976-08-05 AT AT581376A patent/AT345464B/de not_active IP Right Cessation
- 1976-08-05 FR FR7623990A patent/FR2320102A1/fr not_active Withdrawn
- 1976-08-05 DK DK354076A patent/DK147727C/da not_active IP Right Cessation
- 1976-08-05 NO NO762713A patent/NO146457C/no unknown
- 1976-08-05 BE BE169573A patent/BE844903A/xx not_active IP Right Cessation
- 1976-08-06 ES ES450520A patent/ES450520A1/es not_active Expired
- 1976-08-06 JP JP51093257A patent/JPS5221313A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NO146457B (no) | 1982-06-28 |
| IL49996A0 (en) | 1976-09-30 |
| NO762713L (en:Method) | 1977-02-08 |
| AU1577576A (en) | 1978-01-12 |
| ZA764052B (en) | 1977-06-29 |
| DK354076A (da) | 1977-02-07 |
| PT65400B (en) | 1978-01-27 |
| DK147727C (da) | 1985-06-17 |
| BE844903A (fr) | 1977-02-07 |
| NO146457C (no) | 1982-10-06 |
| IL49996A (en) | 1981-01-30 |
| GB1546933A (en) | 1979-05-31 |
| DE2633943A1 (de) | 1977-02-17 |
| AR210501A1 (es) | 1977-08-15 |
| PT65400A (en) | 1976-08-01 |
| AU500641B2 (en) | 1979-05-31 |
| CA1069823A (en) | 1980-01-15 |
| FR2320102A1 (fr) | 1977-03-04 |
| SE431716B (sv) | 1984-02-27 |
| EG12425A (en) | 1979-06-30 |
| JPS5221313A (en) | 1977-02-17 |
| SE7608810L (sv) | 1977-02-07 |
| AT345464B (de) | 1978-09-25 |
| DK147727B (da) | 1984-11-26 |
| ATA581376A (de) | 1978-01-15 |
| NL7608575A (nl) | 1977-02-08 |
| FI762171A7 (en:Method) | 1977-02-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO971986L (no) | Fremgangsmåte for fremstilling av små partikler | |
| SG48087G (en) | Orally administrable antidiabetic compositions | |
| FI831998A7 (fi) | Menetelmä farmaseuttisesti aktiivisten pyratsinonijohdannaisten valmistamiseksi. | |
| FI871209A0 (fi) | Foerfarande foer framstaellning av synnerligen rent dermatansulfat och detta innehaollande farmaceutiska produkter. | |
| HU171226B (hu) | Insekticidnye, akaricidnye i fungicidnye kompozicii, i sposob poluchenija proizvodnykh amidokarbonil-tiobarbiturovojj kisloty i soli primenimykh aktivnymi agentami | |
| ES450520A1 (es) | Procedimiento para la obtencion de soluciones solubilizablesy estabilizadas de 2-cloro-11-(4-metil-i-piperazinil)-dibenz(b,f) (1,4) oxazepina. | |
| IL49391A (en) | 6-chloro-2-(1-piperazinyl)pyrazine and acid addition salts, their preparation and pharmaceutical compositions containing them | |
| ES455691A1 (es) | Procedimiento para la produccion de derivados de piperacina. | |
| JPS523832A (en) | Gel fragrant deodorant | |
| SE7811455L (sv) | 2-imino-imidazolidin-derivat | |
| SE8401234D0 (sv) | Farmaceutiska kompositioner med antineoplastisk aktivitet | |
| ES388882A1 (es) | Procedimiento para la preparacion de 1-(2-nitrilofenoxi)-2-hidroxi-3-etilaminopropano racemicos u opticamente activo. | |
| NL190371C (nl) | Cycloalkanonoximethers met therapeutische eigenschappen en zuuradditiezouten en quaternaire ammoniumderivaten daarvan, alsmede farmaceutische samenstellingen, die deze verbindingen bevatten, en werkwijze voor de bereiding van de verbindingen. | |
| ATE151770T1 (de) | Cephalosporinverbindungen und deren herstellung | |
| PE20010209A1 (es) | Polimorfos de un citrato de azobiciclo[2,2,2] octan-3-amina y sus composiciones farmaceuticas | |
| NO872574L (no) | Fremgangsmte for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler. | |
| NL7703369A (nl) | Werkwijze voor de bereiding van zeer zuiver kristallijn chenodesoxycholzuur. | |
| ES8503649A1 (es) | Procedimiento para preparar esteres de acidos benzosulfonicos substituidos | |
| SE7906681L (sv) | Ftalazonderivat | |
| ES8300747A1 (es) | Procedimiento para la preparacion de derivados de acido in- dolacetico | |
| JPS525769A (en) | Preparation of 3-substituted pyrolidine derivatives | |
| JPS5278887A (en) | Synthesis of n-(2-tetrahydrofuryl)-5-fluorouracil | |
| JPS5289629A (en) | Dopamine derivatives and medicaments containing the same | |
| NO176179C (no) | Analogifremgangsmåte for fremstilling av nye terapeutisk aktive 2-substituerte N,N'-di(trimetoksybenzoyl)piperaziner | |
| BE830481A (fr) | Procede de preparation de composes de 4-halo-4',4"-diarylamino-triphenyl-methanes symetriques |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19991007 |